Apremilast as an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses. J of Skin [Internet]. 2021 May 21 [cited 2025 May 16];5(3):203-27. Available from: https://skin.dermsquared.com/skin/article/view/1239